Anatomical-Clinical Pancreatic Adenocarcinoma Database FRESH-PEF38993-en Barbara BOURNET Anatomical-Clinical Pancreatic Adenocarcinoma Database BACAP FRESH-PEF38993-en 38993 FRESH-PEF38993 Barbara BOURNET Cindy CANIVET CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT) Epidemiology France Portal (PEF) INSTITUT NATIONAL DU CANCER (INCA) null Barbara;BOURNET Cindy;CANIVET Clinical data biological specimens pancreatic carcinogenesis therapeutic target cachexia biomarker proteomics signature genomic DNA microparticles diagnosis screening microRNA Oncology Gastroenterology Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues Biological determinants: Genetic predisposition Behavioral determinants Behavioral determinants: Eating habits Healthcare system determinants: Use of care Socio-demographic and economic determinants: Employment Biological determinants Healthcare system determinants Socio-demographic and economic determinants The purpose of this project is to compile clinical data and data on biological specimens from patients with a pancreatic adenocarcinoma in order to make it available to the scientific community. The purpose of BACAP is to support the following research projects: - understanding the development of pancreatic carcinogenesis, - the early diagnosis and screening of pancreatic cancer by identifying biomarkers of precancerous lesions (proteomics signature, microRNA, genomic dNA, microparticles) and associated thrombosis risk, - the development of new in vitro tools for diagnosing pancreatic cancer, - the clinical and biological evaluation of the development of cachexia in patients with pancreatic cancer, - the determination of factors responsible for spreading cancerous cells, especially inflammation markers, - the identification of biomarkers that indicate sensitivity or resistance to chemotherapy in pancreatic cancer, - the development of new therapeutic targets null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Patients with cytologically and/or histologically proven pancreatic adenocarcinoma Clinical data Participant-reported health data Biological data Paraclinical data (non-biological) : Imaging Paraclinical data (non-biological) : Other Clinsight software the database is managed by the ICM data handling centre Health event/mortality Other Through organizations (health services or institutions schools businesses etc.) [1000-10000[ individuals Other Observational Study Observational Study 1250 Unknown Restricted access The data and the biological specimens are accessible upon request. The request form is accessible on the database website. Each request will be examined by the database's scientific committee. Access on specific project only